Therefore, we aimed to investigate the effects of BRD4 on hepatocellular lipotoxicity, as well as to explore whether BRD4 is involved in activating the NLRP3 inflammasome and promoting hepatocyte pyroptosis during MASLD pathogenesis. Here, BRD4 is linked to metabolic dysfunction-associated steatotic liver disease.